Centre for Innovation in Infectious Disease and Immunology Research
CIIDIR is a new initiative of the Deakin University and Barwon Health partnership that will leverage existing strengths in human infectious disease, microbiome and immunology research. Find out moreAbout
Fostering cross-disciplinary collaboration
Led by Infection, Immunity and Cancer (IIC) researchers Professor Alyssa Barry and Professor Eugene Athan, CIIDIR will foster cross-disciplinary collaboration to conduct innovative, locally relevant and internationally important research. This work will enhance the prevention, control and treatment of some of our most challenging infectious diseases like staphylococcal infections, COVID-19 and Buruli ulcer and immune-mediated diseases such as food allergies, asthma and childhood-onset diabetes).
Find out more
Research Pillars
Molecular Microbiology
Fundamental research on host-pathogen and medical device interactions to uncover biological pathways that are critical for infection and inflammation.
Immunity and Inflammation
Basic and translational research on immunity and inflammation, and microbial diversity (pathogens and microbiome) to inform vaccine and biomarker development and therapeutic interventions.
Population Health and Biology
Epidemiology and surveillance to understand patterns of disease and disease transmission in human populations, and development of innovative approaches for surveillance.
Clinical and Public Health Research
Clinical studies of infectious disease and immune disorders. Including implementation and operational research on public health interventions.Twitter Feed
Meet @paolo_bareng from @CIIDIR_Hub!
His PhD on Plasmodium vivax malaria aimed to understand how the parasite evades the immune system - aiming to improve vaccine design and our understanding of parasite-host interactions.
Read more: https://deakin.au/3YJXG3N
@deakinresearch
School of Medicine honours applications for 2025 are due on 24/10! Areas include cancer, virology, immunology, neuroscience and mental health, amongst others. See projects: http://med-projects.deakin.edu.au & connect with experts using http://experts.deakin.edu.au! @IMPACTDeakin
@CIIDIR_Hub
Our 2024 IMPACT Showcase has begun! We’re excited to hear about the innovative research being undertaken at @IMPACTDeakin as our experts share their latest breakthroughs - creating real-world impact!
That's a wrap on the #GEM2024 conference!
What an incredible three days filled with inspiring connections, learning, and a vibrant exchange of ideas on the latest developments in malaria genomic epidemiology.
Be sure to follow us to continue the conversation & stay connected✨
Latest News & Events
Australian Rickettsial Reference Laboratory (ARRL) moved to Heath Education and Research Building (HERB)
In August, the HERB CIIDIR team welcomed a new team to our office and Laboratory, the Australian Rickettsial Reference Laboratory (ARRL). Originally based across Ryrie St, they have now moved on level 3 within the CIIDIR team. ARRL’s multidisciplinary team includes four main projects: Q fever human vaccine The ARRL in conjunction with the19th International Symposium on Staphylococci and Staphylococcal Infections
18 – 21 August 2024 in Perth, Australia. held at the Perth Convention and Exhibition Centre located in the heart of the city. From the 18th to the 21st of August, CIIDIR members Prof. Catherine Bennett, Dr. Carly Botheras and Dr. Eric Lau, attended the 19th International Symposium on Staphylococci and Staphylococcal Infections. Held at
Robert Ader New Investigator Award winner
Congratulations to the Robert Ader New Investigator Award winner, CIIDIR’s Senior Research Fellow, Dr Luba Sominsky. What is the Robert Ader New Investigator Award? In honour of Dr. Robert Ader, a pioneer in the field of psychoneuroimmunology, the PsychoNeuroImmunology Research Society (PNIRS) presents the Robert Ader New Investigator Award. This prestigious award is presentedSubscribe to our newsletter
Stay up to date on the latest news and events from CIIDIR.